Translational Research on Prescription Drug Abuse

处方药滥用的转化研究

• 批准号: 7874693
• 负责人: JIANREN MAO
• 金额: $ 94.87万
• 依托单位: MASSACHUSETTS GENERAL HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-09-15 至 2012-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7874693
• 关键词: Translational; Research; Prescription; Drug; Abuse

DESCRIPTION (provided by applicant): This proposal is submitted in response to RFA-DA-08-022. Our overall goal is to develop a multidisciplinary P20 research center that conducts basic science and clinical research on the neurobiology and molecular mechanisms of prescription drug abuse. Although addiction to prescription drugs and illicit drugs has many similar features, prescription drug abuse in the setting of legitimate medical use is a unique form of drug addiction that remains to be investigated. Indeed, significant concerns over prescription drug abuse have grown over recent years. Therefore, establishing a translational research center entirely dedicated to this line of research will be novel, timely and clinically relevant. In the scientific research plan of the proposed P20 center, we will study neuroimaging and molecular mechanisms of addiction to opioid analgesics and its interaction with clinical and experimental pain. Three specific aims will be proposed for the overall research plan: 1) to examine behavioral and neuroimaging changes in relation to the interaction between pain and opioid addiction in human subjects and rodents, 2) to explore the role of the brain dopaminergic system in the interaction between pain and opioid addiction, and 3) to investigate the molecular mechanisms underlying the functional role of brain dopamine receptors in the interaction between pain and opioid addiction. The data generated from this research plan will provide novel information on the neural and molecular mechanisms of opioid addiction and its interaction with clinical pain. The operational plan of this P20 center will include both short-term and long-term goals. The short-term goals of this P20 center are to 1) develop and consolidate infrastructures, 2) foster interdisciplinary, collaborative basic science and clinical research, and 3) generate scientific data according to proposed specific aims. The long-term goals are to 1) prepare logistic and administrative needs for the future P50 research center and 2) generate preliminary data for future studies under the P50 research center. The successful implementation of the research and operational plan outlined for this P20 center will lead to the formation of a multidisciplinary P50 research center with expanded research objectives to study the clinical neurobiology and molecular mechanisms of prescription drug abuse.

描述（由申请人提供）： 本提案是根据RFA-DA-08-022提交的。我们的总体目标是建立一个多学科的P20研究中心，对处方药滥用的神经生物学和分子机制进行基础科学和临床研究。虽然处方药成瘾和非法药物成瘾有许多相似的特征，但在合法医疗使用的情况下滥用处方药是一种独特的药物成瘾形式，仍有待调查。事实上，近年来对处方药滥用的严重关切有所增加。因此，建立一个完全致力于这一研究领域的转化研究中心将是新颖的，及时的和临床相关的。在拟建的P20中心的科研计划中，我们将研究阿片类镇痛药成瘾的神经影像学和分子机制及其与临床和实验性疼痛的相互作用。总体研究计划将提出三个具体目标：1）检查人类受试者和啮齿动物中与疼痛和阿片类药物成瘾之间的相互作用相关的行为和神经影像学变化，2）探索大脑多巴胺能系统在疼痛和阿片类药物成瘾之间的相互作用中的作用，3）探讨脑多巴胺受体在疼痛与阿片成瘾相互作用中的分子机制。这项研究计划产生的数据将提供阿片类药物成瘾的神经和分子机制及其与临床疼痛相互作用的新信息。该P20中心的运营计划将包括短期和长期目标。P20中心的短期目标是：1）发展和巩固基础设施，2）促进跨学科的合作基础科学和临床研究，3）根据提出的具体目标生成科学数据。长期目标是1）为未来的P50研究中心准备后勤和行政需求，2）为P50研究中心未来的研究提供初步数据。为该P20中心概述的研究和运营计划的成功实施将导致形成一个多学科的P50研究中心，其研究目标扩大到研究处方药滥用的临床神经生物学和分子机制。